PASS THE CANS CERTIFICATION EXAM WITH CONFIDENCE!
This comprehensive practice question bank features 250+ exam-style questions with verified answers and detailed rationales, covering ALL essential topics for the Certified Aesthetic Nurse Specialist (CANS) Exam for the academic year. Updated per the latest PSNCB guidelines. Perfect for aesthetic nurses, injectors, and certification candidates.
COMPLETE COVERAGE OF ALL EXAM TOPICS:
SECTION I: Aesthetic Injectables - Neurotoxins (Botulinum Toxin Type A)
Anatomy of the Face for Injection (Q1-10)
Corrugator Supercilii, Procerus, Frontalis, Orbicularis Oculi
Depressor Anguli Oris (DAO), Mentalis, Nasalis
Supraorbital Nerve, Facial Nerve (CN VII)
Muscles of Facial Expression vs. Mastication
Botulinum Toxin Pharmacology & Mechanism (Q11-20)
Acetylcholine Release Inhibition
Product Comparison (Botox®, Dysport®, Xeomin®, Jeuveau®)
Onset (1-3 Days), Peak (7-14 Days), Duration (3-4 Months)
Dose Conversion (Botox:Dysport = 1:3)
Heavy Chain vs. Light Chain Function
Indications & Treatment Sites (Q21-30)
FDA-Approved: Glabellar Lines (20 Units)
Off-Label: Crow's Feet, Forehead Lines, Bunny Lines
Nefertiti Lift (Platysma), Lip Flip (Orbicularis Oris)
Gummy Smile (Levator Labii Superioris)
Masseter Hypertrophy, Marionette Lines (DAO)
Contraindications (Pregnancy, Myasthenia Gravis)
Complications (Ptosis, Spocking/Mephisto Sign, Diplopia)
Dosing, Reconstitution & Storage (Q31-40)
Reconstitution Volumes (2.5 mL for 100-unit Botox)
Diluent: Preservative-Free Normal Saline
Storage (Refrigerated, 24-Hour Use After Reconstitution)
Maximum Dose (50 Units per Session)
Swirl Gently, Do Not Shake
Complications & Management (Q41-50)
Brow Ptosis (Observation, Resolves 2-3 Months)
Eyelid Ptosis (Aproclonidine 0.5%)
Diplopia (Lateral Rectus Diffusion)
Dysphagia (Platysmal Bands)
Asymmetrical Smile, Spocking Sign
Risk Reduction (Inject 1 cm Above Orbital Rim)
SECTION II: Aesthetic Injectables - Dermal Fillers
Filler Types & Composition (Q56-70)
Hyaluronic Acid (HA) Fillers: Restylane®, Juvederm®, Belotero®
Cross-Linking Agent: BDDE (Butanediol Diglycidyl Ether)
Calcium Hydroxylapatite (CaHA): Radiesse®
Poly-L-Lactic Acid (PLLA): Sculptra®
PMMA: Bellafill® (Permanent Filler)
Non-HA Fillers: Mechanism of Action
HA Filler Properties & Products (Q71-80)
Vycross® Technology (Juvederm®)
NASHA® Technology (Restylane®)
CPM® Technology (Belotero®)
Juvederm® Voluma (Cheek Augmentation)
Restylane® Lyft (Nasolabial Folds, Cheeks)
Restylane® Silk/Kysse (Lip Augmentation)
Belotero® Balance (Tear Trough, Fine Lines)
Tyndall Effect (Bluish Discoloration from Superficial Injection)
Non-HA Fillers (Q81-90)
Radiesse®: Immediate Volumization + Collagen Stimulation
Sculptra®: 2-3 Sessions, 2-Year Duration, 24-72 Hour Reconstitution
Bellafill®: 20% PMMA + 80% Bovine Collagen, Skin Test Required
Filler Injection Techniques & Anatomy (Q91-100)
Blunt-Tip Cannula (Reduced Vascular Occlusion Risk)
Danger Triangle (Facial Artery, Angular Artery)
Retrograde (Linear Threading) Technique
Supraperiosteal Depth for Midface
Micro-Droplet Technique for Tear Trough
30-45 Degree Needle Insertion Angle
Avoid Infraorbital Nerve (Cheek Injections)
Filler Complications & Management (Q101-110)
Vascular Occlusion (Most Serious Complication)
Early Signs: Pain, Blanching, Delayed Capillary Refill
Hyaluronidase for HA Filler Reversal
Nodule Treatment (Hyaluronidase, Steroids, Massage)
Granuloma Formation (Late Complication of Permanent Fillers)
Herpes Simplex Prophylaxis (Oral Antivirals)
SECTION III: Sclerotherapy
Indications & Technique (Q111-120)
Spider Veins (Telangiectasias) and Reticular Veins
Sodium Tetradecyl Sulfate (STS), Polidocanol
30-Gauge Needle, Compression Stockings (1-2 Weeks)
Hyperpigmentation (Most Common Side Effect)
Pregnancy Contraindication
Matting Treatment (Additional Sclerotherapy, Laser, Compression)
SECTION IV: Laser, Light & Energy-Based Therapies
Laser Physics & Tissue Interaction (Q121-130)
Laser Acronym: Light Amplification by Stimulated Emission of Radiation
Wavelength Determines Depth and Target Chromophore
Chromophores: Melanin, Hemoglobin, Water
Selective Photothermolysis Principle
Thermal Relaxation Time (TRT)
Nd:YAG 1064 nm (Deepest Penetration)
Ablative Lasers (CO₂ & Erbium) (Q131-140)
CO₂ Laser (10,600 nm) - Greater Thermal Coagulation
Er:YAG Laser (2940 nm) - More Ablative
Fractional Ablative Lasers (Microscopic Treatment Zones)
Indications: Photoaging, Wrinkles, Scars
Downtime: 1-2 Weeks (CO₂)
Contraindications: Herpes Simplex (Prophylaxis Needed)
Most Common Complication: Erythema
Non-Ablative Lasers & Fractional Resurfacing (Q141-150)
Preserve Epidermis, Heat Dermis
1064 nm Nd:YAG Non-Ablative Laser
1550 nm Erbium-Doped Fiber (Non-Ablative Fractional)
Indications: Mild to Moderate Photoaging, Skin Tightening
3-5 Treatments for Optimal Results
Shorter Downtime than Ablative Lasers
Intense Pulsed Light (IPL) (Q151-160)
Broad Spectrum (500-1200 nm), Multiple Chromophores
Indications: Pigmented Lesions, Vascular Lesions, Photoaging
Ideal Candidate: Light Skin, Dark Hair
Cooling Mechanism (Protects Epidermis)
3-4 Week Treatment Interval
Contraindications: Active Tan, Recent Isotretinoin
Vascular & Pigment-Specific Lasers (Q161-170)
532 nm KTP, 585 nm Pulsed Dye Laser (Vascular)
Q-Switched Nd:YAG 1064 nm (Tattoos, Deep Pigment)
Q-Switched Ruby 694 nm (Pigmented Lesions)
755 nm Alexandrite (Hair Removal, Pigmented Lesions)
Port-Wine Stains (Pulsed Dye Laser)
Most Common Complication: Hypopigmentation/Hyperpigmentation
Energy Devices (RF, Ultrasound, Cryolipolysis) (Q171-180)
Radiofrequency (Heat from Electrical Resistance)
Skin Laxity (Mild to Moderate)
Ultherapy® (Microfocused Ultrasound, 1.5-4.5 mm Depth)
Cryolipolysis (Freezing-Induced Apoptosis)
Kybella® (Deoxycholic Acid for Submental Fat)
Paradoxical Adipose Hyperplasia (Cryolipolysis Complication)
Laser Safety & Complications (Q181-195)
Eye Protection (Most Important Safety Measure)
Amber/Red for 1064 nm Nd:YAG
Maximum Permissible Exposure (MPE)
Laser Plume (Hazardous Chemicals, Viable Cells)
Higher Risk: Fitzpatrick Skin Types IV-VI
Post-Inflammatory Hyperpigmentation (PIH)
Test Spots, Avoid Sun Exposure
SECTION V: Clinical Skin Care
Skin Anatomy & Physiology (Q196-205)
Keratinocytes (Epidermis), Stratum Basale (Stem Cells)
Dermis (Collagen, Elastin)
Intrinsic Aging (Genetics, Chronological)
Melanocytes (Pigment Production)
Skin pH (4.5-5.5, Acid Mantle)
TEWL (Transepidermal Water Loss)
Fitzpatrick Skin Types
Chemical Peels (Q206-215)
Superficial: Glycolic Acid 30%
Medium: TCA 20-35%
Deep: Phenol (Baker-Gordon)
Indications: Photoaging, Dyschromia, Acne
2-4 Week Interval Between Treatments
Contraindications: Active Herpes Simplex
Post-Peel: Sun Protection, Gentle Cleansing, Moisturizing
Topical Skincare & Wound Healing (Q216-230)
Tretinoin (Increases Cell Turnover, Collagen)
Hydroquinone (Melanin Inhibition)
Vitamin C (Collagen Synthesis, Antioxidant)
SPF 30 = 97% UVB Protection
Chemical vs. Physical Sunscreens
Wound Healing: Inflammation, Proliferation, Remodeling
Silicone Scar Management
Intralesional Steroids (Most Effective for Hypertrophic Scars)
Microneedling (Micro-Injuries Stimulate Collagen)
Contraindications: Active Infection/Herpes
SECTION VI: Patient Assessment, Consultation & Ethics
Patient History & Physical Assessment (Q231-240)
3 Ps: Past Medical History, Physical Exam, Patient Expectations
Medications Review (Anticoagulants, Antiplatelets)
Informed Consent (Risks, Benefits, Alternatives, Limitations)
Body Dysmorphic Disorder (Red Flag)
SOAP Documentation
Pre-Treatment Photography (Standardized Lighting/Positioning)
Photography & Documentation (Q241-245)
Standard Views: Frontal, Right Lateral, Left Lateral
Neutral Background (Blue/Gray)
HIPAA-Compliant Storage
Informed Consent for Photography
Legal, Ethical & Regulatory Considerations (Q246-255)
Scope of Practice (State Board of Nursing)
Standard of Care (Reasonable & Prudent Nurse)
HIPAA (Patient Privacy Protection)
Non-Maleficence (Do No Harm)
CANS Certification (Continuing Education, RN License, Renewal Fee)
WHAT MAKES THIS RESOURCE UNIQUE:
250+ exam-style questions with verified correct answers
Detailed rationales explaining WHY each answer is correct AND why distractors are wrong
Covers ALL CANS exam domains
Updated per latest PSNCB guidelines for
Comprehensive coverage of neurotoxins, fillers, lasers, and skincare
Anatomy, pharmacology, and clinical application
Complication management and safety protocols
Perfect for self-assessment, exam simulation, and identifying weak areas
No fluff - every question directly relevant to exam objectives
BONUS CONTENT:
Comprehensive rationales for every answer
Product comparisons and dosing guidelines
Clinical scenario applications
Safety and complication management
SUITABLE FOR:
CANS certification candidates
Aesthetic nurse specialists
Nurse injectors
Medical aesthetics professionals
Continuing education and exam review
GUARANTEED SUCCESS! Practice with the most comprehensive CANS exam question bank available. Walk into your aesthetic nursing certification exam with confidence!
Content preview
Page 1 of 145
CANS CERTIFIED AESTHETIC NURSE
SPECIALIST PRACTICE EXAM
250+ QUESTIONS & ANSWERS WITH
RATIONALES
2026–2027 ACADEMIC YEAR | UPDATED
PER LATEST PSNCB GUIDELINES
# SECTION I: AESTHETIC INJECTABLES – NEUROTOXINS
## Anatomy of the Face for Injection
### Q1. Which muscle is the primary target for treating glabellar lines (frown lines) with
botulinum toxin?
A) Orbicularis oculi
B) Procerus
C) Corrugator supercilii
D) Frontalis
**Correct Answer: C) Corrugator supercilii**
**Rationale:** The corrugator supercilii muscle is the primary muscle responsible for vertical
glabellar lines (the "11" lines between the eyebrows). It originates from the medial orbital rim
,Page 2 of 145
and inserts into the skin of the medial eyebrow, pulling the brow downward and medially. While
the procerus (B) contributes to horizontal glabellar lines and the orbicularis oculi (A) is targeted
for crow's feet, the corrugator supercilii is the main muscle for vertical glabellar lines. The
frontalis (D) is targeted for horizontal forehead lines.
---
### Q2. Which muscle is responsible for elevating the eyebrows and creating horizontal
forehead lines?
A) Corrugator supercilii
B) Procerus
C) Orbicularis oculi
D) Frontalis
**Correct Answer: D) Frontalis**
**Rationale:** The frontalis muscle is the primary elevator of the eyebrows. It originates from
the galea aponeurotica and inserts into the skin of the forehead and eyebrows. Contraction of the
frontalis creates horizontal forehead lines. The corrugator supercilii (A) and procerus (B) are
brow depressors, while the orbicularis oculi (C) is responsible for eyelid closure and crow's feet.
---
### Q3. The orbicularis oculi muscle is targeted for which aesthetic indication?
A) Glabellar lines
B) Horizontal forehead lines
C) Lateral canthal lines (crow's feet)
,Page 3 of 145
D) Nasal flare
**Correct Answer: C) Lateral canthal lines (crow's feet)**
**Rationale:** The orbicularis oculi is the sphincter muscle surrounding the eye. Its lateral
fibers are responsible for crow's feet (lateral canthal lines) that appear with smiling. Botulinum
toxin is injected into the lateral orbicularis oculi to soften these dynamic wrinkles. The glabellar
lines (A) are treated by targeting the corrugator and procerus muscles, forehead lines (B) by
targeting the frontalis, and nasal flare (D) by targeting the nasalis.
---
### Q4. The depressor anguli oris (DAO) muscle is targeted to treat which concern?
A) Gummy smile
B) Marionette lines
C) Bunny lines
D) Peau d'orange chin
**Correct Answer: B) Marionette lines**
**Rationale:** The depressor anguli oris (DAO) muscle pulls the corners of the mouth
downward. Overactivity of the DAO contributes to marionette lines (melomental folds) that
extend from the corners of the mouth downward. Botulinum toxin injected into the DAO can
soften these lines. Gummy smile (A) is treated by targeting the levator labii superioris; bunny
lines (C) by targeting the nasalis; and peau d'orange chin (D) by targeting the mentalis.
---
, Page 4 of 145
### Q5. Which structure must the injector avoid when treating the glabellar complex to prevent
ptosis?
A) Supraorbital artery
B) Supratrochlear artery
C) Supraorbital nerve
D) Supratrochlear nerve
**Correct Answer: C) Supraorbital nerve**
**Rationale:** The supraorbital nerve exits the supraorbital foramen and provides sensation to
the forehead and scalp. While all listed structures are in the glabellar region, the supraorbital
nerve is the key structure to avoid when injecting the glabellar complex. Injecting too deep or too
lateral can cause brow ptosis by affecting the frontalis muscle, but the supraorbital nerve itself is
a sensory nerve—the risk of ptosis comes from inadvertent diffusion of toxin to the levator
palpebrae superioris or frontalis, not nerve injury. The correct answer focuses on the anatomical
structure at risk.
---
### Q6. The mentalis muscle is targeted for which aesthetic indication?
A) Bunny lines
B) Chin dimpling (peau d'orange)
C) Gummy smile
D) Nasolabial folds
**Correct Answer: B) Chin dimpling (peau d'orange)**